Dld Asset Management, LP Tg Therapeutics, Inc. Transaction History
Dld Asset Management, LP
- $413 Million
- Q2 2025
A detailed history of Dld Asset Management, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 62,500 shares of TGTX stock, worth $2.29 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
62,500Holding current value
$2.29 Million% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$580 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$418 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$280 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$128 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$112 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.33B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...